Validation of a structural comparison of the antigenic characteristics of Usutu virus and West Nile virus envelope proteins

Virus Research

Volumn 189, Issue , 2014, Pages 87-91

  Nikolay, Birgit ^a,b,c   Fall, Gamou ^a   Boye, Cheikh Saad Bouh ^c   Sall, Amadou Alpha ^a   Skern, Tim ^d  

^a INSTITUT PASTEUR DE DAKAR   (Senegal)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antigenic cross reaction; E16 antibody; Envelope protein; Usutu virus; West nile virus

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS ENVELOPE PROTEIN; VIRUS ANTIBODY; VIRUS ANTIGEN;

AMINO ACID SEQUENCE; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; BINDING SITE; CROSS REACTION; FLAVIVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN STRUCTURE; SEQUENCE ALIGNMENT; USUTU FLAVIVIRUS; VALIDATION STUDY; VIRUS NEUTRALIZATION; WEST NILE FLAVIVIRUS; ANIMAL; GENETICS; IMMUNOLOGY; JAPANESE ENCEPHALITIS VIRUS; MOUSE; SEQUENCE HOMOLOGY;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CROSS REACTIONS; ENCEPHALITIS VIRUSES, JAPANESE; MICE; SEQUENCE HOMOLOGY; VIRAL ENVELOPE PROTEINS;

EID: 84905967999     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2014.05.018     Document Type: Article

References (11)

1. Heinz F.X. Epitope mapping of flavivirus glycoproteins. Adv. Virus Res. 1986, 31:103-168.
2. Hurrelbrink R.J., McMinn P.C. Molecular determinants of virulence: the structural and functional basis for flavivirus attenuation. Adv. Virus Res. 2003, 60:1-42.
3. Kanai R., Kar K., Anthony K., Gould L.H., Ledizet M., Fikrig E., Marasco W.A., Koski R.A., Modis Y. Crystal structure of West Nile virus envelope glycoprotein reveals viral surface epitopes. J. Virol. 2006, 80(22):11000-11008.
4. Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., Valentin F., Wallace I.M., Wilm A., Lopez R., Thompson J.D., Gibson T.J., Higgins D.G. Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23(21):2947-2948.
5. Nikolay B., Dupressoir A., Firth C., Faye O., Boye C.S., Diallo M., Sall A.A. Comparative full length genome sequence analysis of Usutu virus isolates from Africa. Virol. J. 2013, 10:217.
6. Nybakken G.E., Nelson C.A., Chen B.R., Diamond M.S., Fremont D.H. Crystal structure of the West Nile virus envelope glycoprotein. J. Virol. 2006, 80(23):11467-11474.
7. Nybakken G.E., Oliphant T., Johnson S., Burke S., Diamond M.S., Fremont D.H. Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature 2005, 437(7059):764-769.
8. Oliphant T., Engle M., Nybakken G.E., Doane C., Johnson S., Huang L., Gorlatov S., Mehlhop E., Marri A., Chung K.M., Ebel G.D., Kramer L.D., Fremont D.H., Diamond M.S. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat. Med. 2005, 11(5):522-530.
9. Poidinger M., Hall R.A., Mackenzie J.S. Molecular characterization of the Japanese encephalitis serocomplex of the flavivirus genus. Virology 1996, 218(2):417-421.
10. Throsby M., Geuijen C., Goudsmit J., Bakker A.Q., Korimbocus J., Kramer R.A., Clijsters-van der Horst M., de Jong M., Jongeneelen M., Thijsse S., Smit R., Visser T.J., Bijl N., Marissen W.E., Loeb M., Kelvin D.J., Preiser W., ter Meulen J., de Kruif J. Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile Virus. J. Virol. 2006, 80(14):6982-6992.
11. Vaszquez A., Jimenez-Clavero M.A., Franco L., Donoso-Mantke O., Sambri V., Niedrig M., Zeller H., Tenorio A. Usutu virus - potential risk of human disease in Europe. Euro Surveill. 2011, 16(31).